Christopher Wu, MD
Rheumatology · Indianapolis, INNPI 1952342305
Payments from drug & device makers
Across 325 payments — averaging $80.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$14K
- Amgen$5K
- Pfizer$2K
- UCB, Inc.$537
- Johnson & Johnson$406
- E.r. Squibb & Sons, L.L.C.$378
- plus $3K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 65 | $14,115 |
| Amgen(2 entities) | 60 | $5,484 |
| Pfizer | 25 | $2,115 |
| UCB, Inc. | 13 | $537 |
| Johnson & Johnson | 16 | $406 |
| E.r. Squibb & Sons, L.L.C. | 25 | $378 |
| Boehringer Ingelheim | 7 | $339 |
| Novartis | 15 | $322 |
| Lilly USA, LLC | 11 | $267 |
| Janssen Scientific Affairs, LLC | 3 | $227 |
| Bristol Myers Squibb | 7 | $191 |
| AstraZeneca(2 entities) | 9 | $188 |
| Genentech USA, Inc. | 5 | $181 |
| Mallinckrodt Enterprises LLC | 10 | $178 |
| Sobi, Inc | 2 | $165 |
| Radius Health, Inc. | 7 | $165 |
| Mallinckrodt Hospital Products Inc. | 2 | $149 |
| Regeneron Healthcare Solutions, Inc. | 7 | $148 |
| Tersera Therapeutics LLC | 3 | $117 |
| GSK | 5 | $68 |
| Aurinia Pharma U.S., Inc. | 3 | $67 |
| Merck | 4 | $56 |
| Ferring Pharmaceuticals Inc. | 3 | $52 |
| Gilead | 2 | $32 |
| Kyowa Kirin, Inc. | 1 | $27 |
| Antares Pharma, Inc. | 2 | $27 |
| Orthogenrx Inc. | 2 | $27 |
| Octapharma USA, Inc. | 1 | $25 |
| Medexus Pharma, Inc. | 2 | $24 |
| Sanofi | 1 | $24 |
| Fidia Pharma USA Inc. | 2 | $22 |
| Organon | 1 | $20 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $18 |
| Celltrion USA Inc. | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
How this compares
$26,211 in reported general payments places this provider in the 85th percentile of 106 rheumatology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Indianapolis
- David BattIndianapolis$577K
- Douglas SmithIndianapolis$147K
- Inna AroutiounovaIndianapolis$102K
- James CohenIndianapolis$76K
- Steven HugenbergIndianapolis$50K
- James EhlichIndianapolis$27K
- Michael StackIndianapolis$21K
- Methee SrivatanaIndianapolis$10K
- Mary JacobsIndianapolis$9K
- Randall ReedIndianapolis$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.